Morgan Stanley upgraded shares of Grifols (NASDAQ:GRFS – Get Rating) from an equal weight rating to an overweight rating in a report issued on Wednesday morning, The Fly reports. A number of other research firms have also recently commented on GRFS. StockNews.com cut Grifols from a buy rating to a hold rating in a research […]
StockNews.com cut shares of Grifols (NASDAQ:GRFS – Get Rating) from a buy rating to a hold rating in a research note released on Monday. GRFS has been the subject of several other reports. Barclays raised shares of Grifols from an underweight rating to an equal weight rating in a report on Thursday, February 16th. Jefferies […]
StockNews.com cut shares of Grifols (NASDAQ:GRFS – Get Rating) from a buy rating to a hold rating in a research note published on Monday morning. Other analysts also recently issued research reports about the stock. AlphaValue raised shares of Grifols to a buy rating in a research report on Monday, February 6th. Barclays raised shares […]
Grifols (NASDAQ:GRFS – Get Rating) was upgraded by Morgan Stanley from an “equal weight” rating to an “overweight” rating in a research note issued on Wednesday, The Fly reports. Several other brokerages have also recently commented on GRFS. AlphaValue upgraded Grifols to a “buy” rating in a report on Monday, February 6th. Barclays upgraded shares […]
Lapides Asset Management LLC lessened its position in shares of Grifols, S.A. (NASDAQ:GRFS – Get Rating) by 39.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 210,600 shares of the biotechnology company’s stock after selling 140,000 shares during the period. Lapides Asset Management […]